197 related articles for article (PubMed ID: 16218046)
1. Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism.
Barbetta L; Dall'Asta C; Re T; Libè R; Costa E; Ambrosi B
J Endocrinol Invest; 2005; 28(7):632-7. PubMed ID: 16218046
[TBL] [Abstract][Full Text] [Related]
2. Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses.
Laureti S; Falorni A; Santeusanio F
J Endocrinol Invest; 2003 Nov; 26(11):1071-5. PubMed ID: 15008243
[TBL] [Abstract][Full Text] [Related]
3. Urine free-cortisol determination. A useful tool in the management of chronic hypoadrenal states.
Burch WM
JAMA; 1982 Apr; 247(14):2002-4. PubMed ID: 7062507
[TBL] [Abstract][Full Text] [Related]
4. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
[TBL] [Abstract][Full Text] [Related]
5. An assessment of optimal hydrocortisone replacement therapy.
Howlett TA
Clin Endocrinol (Oxf); 1997 Mar; 46(3):263-8. PubMed ID: 9156032
[TBL] [Abstract][Full Text] [Related]
6. Dose distribution in hydrocortisone replacement therapy has a significant influence on urine free cortisol excretion.
Bliesener N; Steckelbroeck S; Redel L; Klingmüller D
Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):443-6. PubMed ID: 14614652
[TBL] [Abstract][Full Text] [Related]
7. Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution.
Blomgren J; Ekman B; Andersson PO; Arnqvist HJ
Scand J Clin Lab Invest; 2004 Apr; 64(2):132-9. PubMed ID: 15115251
[TBL] [Abstract][Full Text] [Related]
8. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements.
Arlt W; Rosenthal C; Hahner S; Allolio B
Clin Endocrinol (Oxf); 2006 Apr; 64(4):384-9. PubMed ID: 16584509
[TBL] [Abstract][Full Text] [Related]
9. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
[TBL] [Abstract][Full Text] [Related]
10. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
[TBL] [Abstract][Full Text] [Related]
11. The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.
Dineen R; Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Keevil BG; Tormey W; Smith D; Thompson CJ; McKenna MJ; Arlt W; Stewart PM; Agha A; Sherlock M
BMC Endocr Disord; 2020 Oct; 20(1):154. PubMed ID: 33036588
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.
Alonso N; Granada ML; Lucas A; Salinas I; Reverter J; Oriol A; Sanmarti A
J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078
[TBL] [Abstract][Full Text] [Related]
13. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
[TBL] [Abstract][Full Text] [Related]
14. Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism.
Watanabe T; Ozawa A; Ishii S; Tomaru T; Shibusawa N; Saito T; Yamada E; Horiguchi K; Nakajima Y; Matsumoto S; Yoshino S; Katano-Toki A; Hashimoto K; Mori M; Okada S; Satoh T; Yamada M
Endocr J; 2018 May; 65(5):547-556. PubMed ID: 29618670
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey SR; Guo CY; Robinson AM; Price A; Giles MA; Eastell R; Weetman AP
Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
[TBL] [Abstract][Full Text] [Related]
16. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency.
Ceccato F; Albiger N; Reimondo G; Frigo AC; Ferasin S; Occhi G; Mantero F; Terzolo M; Scaroni C
Eur J Endocrinol; 2012 Dec; 167(6):769-76. PubMed ID: 23034783
[TBL] [Abstract][Full Text] [Related]
17. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
Murray RD; Ekman B; Uddin S; Marelli C; Quinkler M; Zelissen PM;
Clin Endocrinol (Oxf); 2017 Mar; 86(3):340-346. PubMed ID: 27801983
[TBL] [Abstract][Full Text] [Related]
18. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.
DeVile CJ; Stanhope R
Clin Endocrinol (Oxf); 1997 Jul; 47(1):37-41. PubMed ID: 9302370
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery.
Prete A; Taylor AE; Bancos I; Smith DJ; Foster MA; Kohler S; Fazal-Sanderson V; Komninos J; O'Neil DM; Vassiliadi DA; Mowatt CJ; Mihai R; Fallowfield JL; Annane D; Lord JM; Keevil BG; Wass JAH; Karavitaki N; Arlt W
J Clin Endocrinol Metab; 2020 Jul; 105(7):2262-74. PubMed ID: 32170323
[TBL] [Abstract][Full Text] [Related]
20. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.
Debono M; Ross RJ; Newell-Price J
Eur J Endocrinol; 2009 May; 160(5):719-29. PubMed ID: 19168600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
